Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

Download

Total Articles

8
(from Reference Citation Analysis)

Article PDFs (0)

Cited by > 0 (0)

Searched Name

Questran

Ranked By

Results Analysis

Year Published Analysis
Article Type Analysis
Publication Title Analysis
Category Analysis

Results Analysis

Indexed Articles

Year Published

Show more Refine

Article Type

Show more Refine

Article Statistics

Refine

MESH Headings

Show more Refine

First Author

Show more Refine

First Author Affiliations

Show more Refine

Authors

Show more Refine

Publication Titles

Show more Refine

Grant Agencies

Show more Refine

Countries/Regions

Show more Refine

Affiliations

Show more Refine

Corresponding Author Affiliations

Show more Refine

Category

Show more Refine

Number	Citation Analysis
1	Lipid-lowering drugs. Med Lett Drugs Ther 2022;64:145-52. [PMID: 36094548] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/15/2023] Abstract Collapse Key Words Altoprev Antara Colestid Crestor Evkeeza Evolocumab Ezallor Sprinkle Fenolglide Juxtapid Leqvio Lescol Lipitor Lipofen Livalo Lopid Lovaza Nexletol Nexlizet Niacor Niaspan Praluent Prevalite Questran Repatha Roszet Slo-Niacin Tricor Trilipix Vascepa Vytorin Welchol Zetia Zocor Flolipid Zypitamag adverse effects alirocumab atorvastain bempedoic acid cholesterol cholestyramine colesevelam colestipol dosage drug interactions efficacy evinacumab ezetimibe fenofibrate fenofibric fluvastatin gemfibrozil icosapent ethyl inclisiran lactation lomitapide lovastatin niacin omega-3 fatty acids pitavastatin pravastatin pregnancy rosuvastatin safety simvastatin statins Collapse MESH Headings Humans Hypolipidemic Agents/adverse effects Lipids Collapse Grants Collapse Affiliation(s) Collapse
2	Comparison table: Some lipid-lowering drugs. Med Lett Drugs Ther 2022;64:e152-8. [PMID: 36094549] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/15/2023] Abstract Collapse Key Words Altoprev Antara Colestid Crestor Ezallor Sprinkle Fenoglide Fibricor Flolipid Lescol Lipitor Lipofen Lodalis Lopid Lovaza Niacor Niaspan Olestyr Praluent Pravachol Prevalite Questran Repatha Slo-Niacin Tricor Triglide Trilipix Vascepa Welchol Zetia Zypitamag adverse effects alirocumab atorvastatin cholesterol cholestyramine colesevelam colestipol dosage drug interactions efficacy evolocumab ezetimibe fenofibrate fenofibric acid fluvastatin gemfibrozil icosapent ethyl lactation lovastatin niacin omega-3 fatty acids pitavastatin pravastatin pregnancy rosuvastatin safety simvastatin statins Collapse MESH Headings Humans Hypolipidemic Agents/adverse effects Lipids Collapse Grants Collapse Affiliation(s) Collapse
3	Drugs for rheumatoid arthritis. Med Lett Drugs Ther 2021;63:177-84. [PMID: 35085210] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/14/2023] Abstract Collapse Key Words Actemra Arava Aristospan Avsola COVID-19 Celebrex Cimzia Comirnaty DMARDs Depo-Medrol Enbrel Humira Inflectra JAK inhibitors Kevzara NSAIDs Olumiant Orencia Otrexup PennSaid Plaquenil Questran Rasuvo Reditrex Remicade Renflexis Riabni Rinvoq Rituxan Ruxience Simponi Spikevax TNF inhibitors Trexall Truxima Voltaren Xatmep Xeljanz abatacept adalimumab adverse effects baricitinib biologic celecoxib certolizumab corticosteroids diclofenac drug interactions etanercept golimumab hydroxychloroquine infliximab lactation leflunomide methotrexate methylprednisolone prednisone pregnancy rheumatoid arthritis rituximab safety sarilumab sulfasalazine tocilizumab tofacitinib triamcinolone upadacitinib vaccines Collapse MESH Headings Antirheumatic Agents/therapeutic use Arthritis, Rheumatoid/drug therapy Humans COVID-19 Drug Treatment Collapse Grants Collapse Affiliation(s) Collapse
4	Drugs for Irritable Bowel Syndrome. Med Lett Drugs Ther 2020;62:25-32. [PMID: 32324172] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/11/2023] Abstract Collapse Key Words 5-HT3 antagonists 5-HT4 agonist Amitiza Anaspaz Bentyl Celexa Colestid Constipation IBgard Ibsrela Imodium Levbid Levsin Linzess Lotronex Lyrica Miralax NHE3 inhibitor Norpramin Pamelor Paxil Pepogest Prozac Questran SSRIs Trulance Viberzi Welchol Xifaxan Zelnorm Zofran adverse effects alosetron amitriptyline antibacterials antidepressants antidiarrheals antispasmodics bile acid sequestrants chloride channel activator cholestyramine citalopram colesevelam colestipol desipramine diarrhea dicyclomine diet dosage drug interactions efficacy eluxadoline exercise fiber fluoxetine guanylate cyclase-c agonists hyoscyamine irritable bowel syndrome linaclotide loperamide lubiprostone nortriptyline ondansetron opioid receptor agonist opioid receptor antagonist osmotic laxatives paroxetine peppermint oil plecanatide polyethylene glycol pregabalin probiotics psyllium rifaximin safety tegaserod tenapanor tricyclic antidepressants Collapse MESH Headings Constipation/drug therapy Constipation/etiology Diarrhea/drug therapy Diarrhea/etiology Gastrointestinal Agents/pharmacology Gastrointestinal Agents/therapeutic use Humans Irritable Bowel Syndrome/drug therapy Irritable Bowel Syndrome/physiopathology Collapse Grants Collapse Affiliation(s) Collapse
5	Table: Safety of drugs for IBS in pregnancy and lactation (online only). Med Lett Drugs Ther 2020;62:e48-9. [PMID: 32324174] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Key Words] [Subscribe] [Scholar Register] [Indexed: 06/11/2023] Abstract Collapse Key Words Amitiza Bentyl Celexa Colestid Ibsrela Levsin Linzess Lotronex Lyrica Motegrity Norpramin Pamelor Paxil Prozac Questran SSRIs Trulance Viberzi Welchol Xifaxan Zelnorm Zofran alosetron amitriptyline cholestyramine citalopram colesevelam colestipol desipramine dicyclomine eluxadoline fluoxetine hyoscyamine irritable bowel syndrome lactation linaclotide lubiprostone nortriptyline ondansetron paroxetine plecanatide pregabalin pregnancy prucalopride rifaximin tegaserod tenapanor tricyclic antidepressants Collapse MESH Headings Collapse Grants Collapse Affiliation(s) Collapse
6	Drugs for psoriatic arthritis. Med Lett Drugs Ther 2019;61:203-10. [PMID: 31999665] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/10/2023] Abstract Collapse Key Words Arava Avsola Azulfidine Brenzys Celebrex Cosentyx DMARDs Enbrel Erelzi Eticovo Gengraf Hadima Humira IL-12/23 inhibitor IL-17A inhibitors Inflectra Ixifi Metoject NSAIDs Neoral Olestyr Orencia Otezla Otrexup PDE4 inhibitors Questran Rasuvo RediTrex Remicade Renflexis Rinvoq Salazopyrin Simponi Stelara T-Cell activation inhibitor TNF inhibitors Taltz Trexall Xeljanz abatacept adalimumab adverse effects apremilast biosimilars celecoxib certolizumab cholestyramine corticosteroids cyclosporine dosage drug interactions efficacy etanercept golimumab infliximab ixekizumab lactation leflunomide methotrexate pregnancy psoriatic arthritis safety secukinumab sulfasalazine tofacitinib upadacitinib ustekinumab Collapse MESH Headings Adrenal Cortex Hormones/administration & dosage Adrenal Cortex Hormones/adverse effects Adrenal Cortex Hormones/therapeutic use Anti-Inflammatory Agents, Non-Steroidal/administration & dosage Anti-Inflammatory Agents, Non-Steroidal/adverse effects Anti-Inflammatory Agents, Non-Steroidal/therapeutic use Antirheumatic Agents/administration & dosage Antirheumatic Agents/adverse effects Antirheumatic Agents/therapeutic use Arthritis, Psoriatic/drug therapy Biological Products/administration & dosage Biological Products/adverse effects Biological Products/therapeutic use Drug Costs Drug Interactions Humans Phosphodiesterase 4 Inhibitors/administration & dosage Phosphodiesterase 4 Inhibitors/adverse effects Phosphodiesterase 4 Inhibitors/therapeutic use Collapse Grants Collapse Affiliation(s) Collapse
7	Lipid-lowering drugs. Med Lett Drugs Ther 2019;61:17-24. [PMID: 30845106] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/09/2023] Abstract Collapse Key Words Altoprev Antara Bezalip Colestid Crestor Epanova Ezetrol Fenoglide Fibricor Flolipid Juxtapid Kynamro Lescol Lipidil Lipitor Lipofen Livalo Lodalis Lopid Niacor Niaspan Olestyr PCSK9 inhibitors Praluent Pravachol Prevalite Questran Repatha Slo-Niacin Tricor Triglide Trilipix Vascepa Vytorin Welchol Zetia Zocor Zypitamag adverse effects alirocumab atorvastatin bezafibrate bile acid sequestrants cholesterol cholesterol absorption inhibitor cholestyramine colesevelam colestipol dosage drug interactions efficacy evolucumab ezetimibe ezetimibe/simvastatin fenofibrate fenofibric acid fish oil fluvastatin gemfibrozil hypercholesterolemia hypertriglyceridemia icosapent ethyl lomitapide lovastatin mipomersen niacin omega-3 fatty acids pitavastatin pravastatin pregnancy rosuvastatin safety simvastatin statins Collapse MESH Headings Drug Interactions Humans Hypercholesterolemia/drug therapy Hypolipidemic Agents/adverse effects Hypolipidemic Agents/therapeutic use Collapse Grants Collapse Affiliation(s) Collapse
8	Comparison table: Some lipid-lowering drugs. Med Lett Drugs Ther 2019;61:e24-30. [PMID: 30845107] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/09/2023] Abstract Collapse Key Words Altoprev Antara Bile acid sequestrants Colestid Crestor Epanova Fenoglide Fibricor Flolipid Lescol Lipitor Lipofen Livalo Lopid Lovaza Niacor Niaspan PCSK9 inhibitors Praluent Pravachol Prevalite Questran Repatha Slo-Niacin Tricor Triglide Trilipix Vytorin Welchol Zetia Zocor Zypitag adverse effects alirocumab atorvastatin cholesterol cholesterol absorption inhibitor cholestyramine colesevelam colestipol dosage drug interactions efficacy evolocumab ezetimibe ezetimibe/simvastatin fenofibrate fenofibric acid fish oil fluvastatin gemfibrozil hypertriglyceridemia icosapent ethyl lovastatin niacin omega-3 fatty acids pitavastatin pravastatin pregnancy rosuvastatin safety simvastatin statins Collapse MESH Headings Dosage Forms Drug Administration Schedule Drug Costs/statistics & numerical data Humans Hypolipidemic Agents/administration & dosage Hypolipidemic Agents/adverse effects Hypolipidemic Agents/economics Collapse Grants Collapse Affiliation(s) Collapse